The addition of high-dose tamoxifen to standard radiotherapy does not improve the survival of patients with diffuse intrinsic pontine glioma

Journal of Neuro-Oncology

Volumn 100, Issue 1, 2010, Pages 81-88

  Michalski, Antony ^h   Bouffet, Eric ^a   Taylor, Roger E ^b   Hargrave, Darren ^c   Walker, David ^d   Picton, Susan ^e   Robinson, Kathryn ^f   Pizer, Barry ^g   Bujkiewicz, Sylwia ^f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SINGLETON HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^h NONE

Author keywords

Corticosteroids; Diffuse intrinsic pontine glioma; Overall survival; Progression free survival; Tamoxifen

Indexed keywords

DEXAMETHASONE; TAMOXIFEN;

ADOLESCENT; APPETITE DISORDER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; DIFFUSE INTRINSIC PONTINE GLIOMA; DOSE RESPONSE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG USE; DRUG WITHDRAWAL; DYSPHAGIA; EVENT FREE SURVIVAL; FEMALE; HUMAN; IRRITABILITY; LIVER TOXICITY; MALE; MOTOR DYSFUNCTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PONTINE GLIOMA; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; SIDE EFFECT; SLEEP DISORDER; SPEECH DISORDER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; WEAKNESS;

ADOLESCENT; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; INFANT; MALE; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT OUTCOME;

EID: 79952149650     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0141-9     Document Type: Article

References (25)

1. Kaplan AM, Albright AL, Zimmerman RA et al (1996) Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg 24:185-192
2. Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7:241-248 (Pubitemid 43286454)
3. Mandell LR, Kadota R, Freeman C et al (1999) There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959-964
4. Kretschmar CS, Tarbell NJ, Barnes PD et al (1993) Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer 72:1404-1413
5. Jenkin RD, Boesel C, Ertel I et al (1987) Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg 66:227-233 (Pubitemid 17027880)
6. Dunkel IJ, Garvin JH Jr, Goldman S et al (1998) High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol 37:67-73 (Pubitemid 28073577)
7. Bouffet E, Raquin M, Doz F et al (2000) Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88:685-692 (Pubitemid 30056946)
8. Doz F, Neuenschwander S, Bouffet E et al (2002) Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie Pediatrique. Eur J Cancer 38:815-819 (Pubitemid 34280327)
9. Walter AW, Gajjar A, Ochs JS et al (1998) Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. Med Pediatr Oncol 30:28-33 (Pubitemid 128765909)
10. Pollack IF, Randall MS, Kristofik MP et al (1990) Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 50:7134-7138
11. Baltuch GH, Couldwell WT, Villemure JG, Yong VW (1993) Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen. Neurosurgery 33:495-501
12. Couldwell WT, Hinton DR, Surnock AA et al (1996) Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin Cancer Res 2:619-622
13. Freeman A, Hetherington M, Egelhof J (1994) Preliminary results: diffuse intrinsic brain stem gliomas of childhood respond to tamoxifen. Proc Am Assoc Cancer Res 35:470
14. Pollack IF, DaRosso RC, Robertson PL et al (1997) A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Clin Cancer Res 3:1109-1115 (Pubitemid 27319757)
15. Broniscer A, Leite CC, Lanchote VL et al (2000) Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol 18:1246-1253 (Pubitemid 30159842)
16. Graff JR, McNulty AM, Hanna KR et al (2005) The protein kinase Cbeta-selective inhibitor, Enzastaurin (LY317615.HCl), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts. Cancer Res 65:7462-7469 (Pubitemid 41161281)
17. Teicher BA (2006) Protein kinase C as a therapeutic target. Clin Cancer Res 12:5336-5345
18. Teicher BA, Menon K, Alvarez E et al (2001) Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts. Clin Cancer Res 7:634-640 (Pubitemid 32707989)
19. Fine HA, Kim L, Royce C et al. (2005) Results from phase II trial of Enzastaurin (LY317615) in patients with recurrent high grade gliomas. J Clin Oncol [2005 ASCO Annual Meeting Proceedings] 23:1504
20. Lewis J, Lucraft H, Gholkar A (1997) UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. Int J Radiat Oncol Biol Phys 38:925-929 (Pubitemid 27353670)
21. Machin D, Cheung Y-B, Parmar MKB (2006) Survival analysis: a practical approach. Wiley, Chichester
22. StataCorp (2007) Statistical Software: Release 10. StataCorp LP, College Station, TX
23. Nowak A, Findlay M, Culjak G, Stockler M (2004) Tamoxifen for hepatocellular carcinoma. In: Cochrane Database of Systematic Reviews http://www.cochrane.org/reviews/en/ab001024.html . Art. No.: CD001024. doi:10.1002/14651858.CD001024.pub2
24. Freeman CR, Krischer J, Sanford RA (1991) Hyperfractionated radiation therapy in brain stem tumors. Cancer 68:474-481
25. Glaser AW, Buxton N, Walker D (1997) Corticosteroids in the management of central nervous system tumours. Arch Dis Child 76:76-78 (Pubitemid 27060501)